Open access
Open access
Powered by Google Translator Translator

Internal Medicine

RCT: Bamlanivimab plus Etesevimab reduce mortality and hospitalization in ambulatory patients with early Covid-19 (within 3 days of a positive test) who are at risk for clinical deterioration (i.e., older people, obese, diabetics, immunocompromised, with CV disease).

15 Jul, 2021 | 09:26h | UTC

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19 – New England Journal of Medicine

 


COVID and the brain: researchers zero in on how damage occurs.

15 Jul, 2021 | 09:18h | UTC

COVID and the brain: researchers zero in on how damage occurs – Nature

 


Study shows the viral loads in the Delta infections are ~1000 times higher than those in the earlier strain infections on the day when viruses are firstly detected.

15 Jul, 2021 | 09:20h | UTC

Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant – Virological.org

Commentary: The Delta Variant Isn’t Just Hyper-Contagious. It Also Grows More Rapidly Inside You – NPR

Related: WHO: Delta variant is ‘most transmissible’ identified so far. AND Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”.

 

Commentary on Twitter

 


[Preprint] Brain imaging before and after COVID-19 in UK Biobank.

15 Jul, 2021 | 09:17h | UTC

Brain imaging before and after COVID-19 in UK Biobank – medRxiv

Commentaries: COVID linked to loss of brain tissue: but correlation doesn’t prove causation – The Conversation AND COVID-19 survivors may suffer from a loss of gray matter and other brain tissue over time, a long-term study suggests – Business Insider

 


Radiation therapy-associated toxicity: Etiology, management, and prevention.

15 Jul, 2021 | 09:13h | UTC

Radiation therapy-associated toxicity: Etiology, management, and prevention – CA: A Cancer Journal for Clinicians

 


Tramadol: Where do we go from here? – “Tramadol’s unpredictability, unique potential harms, and lack of advantage over other opioids or NSAIDs are now well recognized”.

15 Jul, 2021 | 09:14h | UTC

[131] Tramadol: Where do we go from here? – Therapeutic Initiative

 


Cohort study: Increased risk of long-term risk of anemia after bariatric surgery – Compared with the control group, the incidence of anemia was higher in the gastric bypass group (HR 5.05), the vertical-banded gastroplasty group (HR 2.67), and the gastric banding group (HR 2.76).

15 Jul, 2021 | 09:10h | UTC

Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)

 


Consensus Guidance: Budd-Chiari syndrome.

15 Jul, 2021 | 09:07h | UTC

Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL) – Hepatology International

 


A consensus integrated care pathway for patients with primary biliary cholangitis.

15 Jul, 2021 | 09:06h | UTC

A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients – Expert Review of Gastroenterology & Hepatology

 


Sarcoidosis: A clinical overview from symptoms to diagnosis.

15 Jul, 2021 | 08:58h | UTC

Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis – Cells

 


Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

15 Jul, 2021 | 09:02h | UTC

Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature – PLOS Neglected Tropical Diseases

 


RCT: Lopinavir-ritonavir and hydroxychloroquine worsened outcomes in critically ill patients with COVID-19.

14 Jul, 2021 | 11:25h | UTC

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial – Intensive Care Medicine

 

Commentary on Twitter (thread – click for more)

 


Opinion | The case for mandating COVID-19 vaccines for health care workers.

14 Jul, 2021 | 11:22h | UTC

The Case for Mandating COVID-19 Vaccines for Health Care Workers – Annals of Internal Medicine

News release: Case is strong for mandating COVID-19 vaccination for health care workers – American College of Physicians

 

Commentary on Twitter

 


RCT: Neither Remdesivir nor Hydroxychloroquine affect viral clearance in hospitalized patients with COVID-19.

14 Jul, 2021 | 11:23h | UTC

News release: Neither remdesivir nor HCQ affect viral clearance in hospitalized patients with COVID-19 – American College of Physicians

Original Study: Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 – Annals of Internal Medicine

 

Commentary on Twitter

 


Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.

14 Jul, 2021 | 11:20h | UTC

Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women – JAMA

Commentary: Pfizer COVID vaccine shows 78% efficacy in pregnancy – CIDRAP

 


Real-World Evidence: The low validity of temperature screening for COVID-19 triage.

14 Jul, 2021 | 11:11h | UTC

Real-World Evidence: The Low Validity of Temperature Screening for COVID-19 Triage – Frontiers in Public Health

 

Commentary on Twitter

 


One COVID vaccine dose yields good protection in elderly, 2 studies find.

14 Jul, 2021 | 11:15h | UTC

One COVID vaccine dose yields good protection in elderly, 2 studies find – CIDRAP

Original study 1: Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study – The Lancet Infectious Diseases

Original Study 2: Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study – The Lancet Infectious Diseases

 

Commentary on Twitter (thread – click for more)

 


WHO: New study highlights unacceptably high global prevalence of syphilis among men who have sex with men.

14 Jul, 2021 | 11:04h | UTC

New study highlights unacceptably high global prevalence of syphilis among men who have sex with men – World Health Organization

Original Study: Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000–20 – The Lancet Global Health

Commentary: Syphilis in men who have sex with men: advancing research and human rights – The Lancet Global Health

 


Global burden of cancer attributable to alcohol consumption – “Globally, an estimated 741.300, or 4·1% of all new cases of cancer in 2020 were attributable to alcohol consumption”.

14 Jul, 2021 | 11:07h | UTC

Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study – The Lancet Oncology

News release: Alcohol consumption linked to more than 740,000 new cancer cases in 2020 – The Lancet

Commentaries: Alcohol caused 740,000 cancer cases globally last year – study – The Guardian AND Expert reaction to study of alcohol and cancer – Science Media Centre

 


Review: Diagnosis and treatment of alcohol-associated liver disease.

14 Jul, 2021 | 11:02h | UTC

Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review – JAMA (free for a limited period)

Audio Clinical Review: Diagnosis and Treatment of Alcohol-Associated Liver Disease – JAMA

 


Summary: SGLT2 inhibitors and GLP-1 receptor agonists established and emerging indications.

14 Jul, 2021 | 10:56h | UTC

SGLT2 Inhibitors and GLP-1 Receptor Agonists: Indications – American College of Cardiology

Original review: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications – The Lancet (link to abstract – $ for full-text)

Related guideline: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes – This guidance recommends a risk-based approach, advising against starting SGLT-2 inhibitors or GLP-1 receptor agonists in patients with three or fewer cardiovascular risk factors and without established CVD or CKD.

 


FDA Safety Alert: hydroxyethyl starch products should not be used unless adequate alternative treatment is unavailable.

14 Jul, 2021 | 10:48h | UTC

Labeling Changes on mortality, kidney injury, and excess bleeding with hydroxyethyl starch products – U.S. Food and Drug Administration

Commentary: FDA Piles on New Warnings for Blood Volume Expanders – MedPage Today (free registration required)

Related: Hydroxyethyl-starch Solutions (HES) Should no Longer be Used – European Medicines Agency AND Randomized Trial: Hydroxyethyl Starch vs. Saline for Volume Replacement Therapy in High-Risk Patients Undergoing Major Abdominal Surgery AND Systematic Review: Colloids vs Crystalloids for Fluid Resuscitation in Critically Ill People

 


German national treatment guidance for hospitalized COVID-19 patients.

13 Jul, 2021 | 10:02h | UTC

Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) – Infection

 


Long Covid: 39% of patients report persistent symptoms more than seven months after diagnosis of COVID-19 in an outpatient setting.

13 Jul, 2021 | 09:57h | UTC

Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting – Annals of Internal Medicine

Commentaries: Long COVID symptoms in a third of people with COVID-19 – American College of Physicians AND Covid-19: 1-in-3 Patients Reported Long-Hauler Symptoms – Physician’s Weekly

 

Commentary on Twitter

 


[Preprint] Long Covid: Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people.

13 Jul, 2021 | 09:55h | UTC

Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people – medRxiv

Commentary: Study explores the prevalence of long COVID in England – News Medical

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.